Silva Pharmaceuticals Limited announced earnings results for the full year ended June 30, 2019. For the full year, the company announced sales was BDT 732.450 million compared to BDT 685.233 million a year ago. Operating income was BDT 150.251 million compared to BDT 147.583 million a year ago. Net income was BDT 143.323 million compared to BDT 92.993 million a year ago. Basic earnings per share was BDT 1.15 compared to BDT 0.93 a year ago.